| Entry |
|
|---|
| Name |
Talibegron hydrochloride (USAN)
|
|---|
| Formula |
C18H21NO4. HCl
|
|---|
| Exact mass |
351.1237
|
|---|
| Mol weight |
351.8246
|
|---|
| Structure |
     |
|---|
| Activity |
Treatment of obesity in dogs and cats [beta-adrenoreceptor agonist]
|
|---|
| Target |
beta1-adrenergic receptor agonist [HSA: 153] [KO: K04141]; beta2-adrenergic receptor agonist [HSA: 154] [KO: K04142]; beta3-adrenergic receptor agonist [HSA: 155] [KO: K04143] |
|---|
| Pathway |
|
|---|
| Interaction |
|
|---|
| Brite |
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Adrenaline
beta1-adrenergic receptor [HSA:153] [KO:K04141]
Talibegron
D02702 Talibegron hydrochloride (USAN)
beta2-adrenergic receptor [HSA:154] [KO:K04142]
Talibegron
D02702 Talibegron hydrochloride (USAN)
beta3-adrenergic receptor [HSA:155] [KO:K04143]
Talibegron
D02702 Talibegron hydrochloride (USAN)
 |
|---|
| Other DBs |
CAS: 178600-17-4 PubChem: LigandBox: |
|---|
| KCF data |
ATOM 24
1 C8x C 15.1200 -22.4700
2 C8x C 15.1200 -21.0700
3 C8x C 16.3100 -20.3700
4 C8x C 17.5700 -21.0700
5 C8y C 17.5700 -22.4700
6 C8x C 16.3100 -23.1700
7 C1c C 18.7600 -23.1700
8 C1b C 20.0200 -22.4700
9 N1b N 21.2100 -23.1700
10 C1b C 22.4000 -22.4700
11 C1b C 23.6600 -23.1700
12 O2a O 24.8500 -22.4700
13 C8y C 26.0400 -23.1700
14 O1a O 18.7600 -24.5700
15 C8x C 27.3000 -22.4700
16 C8x C 28.4900 -23.1700
17 C8y C 28.4900 -24.5700
18 C8x C 27.3000 -25.2700
19 C8x C 26.0400 -24.5700
20 C1b C 29.6800 -25.2700
21 C6a C 30.9400 -24.5700
22 O6a O 32.1300 -25.2700
23 O6a O 30.9400 -23.1700
24 X Cl 27.3700 -27.3000
BOND 24
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 5 7 1
8 7 8 1
9 8 9 1
10 9 10 1
11 10 11 1
12 11 12 1
13 12 13 1
14 7 14 1 #Down
15 13 15 2
16 15 16 1
17 16 17 2
18 17 18 1
19 18 19 2
20 13 19 1
21 17 20 1
22 20 21 1
23 21 22 1
24 21 23 2
|
|---|
